Low grade gliomas Flashcards
What are Low Grade gliomas?
Diffuse astrocytoma
Oligodendroglioma
What are High Grade gliomas?
Glioblastoma
Astrocytoma
What are Benign gliomas?
Pituitary
Meningioma
Where do low grade gliomas originate?
Develop from glial cells (neuroglial cells)
Glia (Greek), Glue (English)
NOT nerve cells (neurons) – not directly involved with electrical signalling and synaptic interactions
Glial cells provide support and protection to neurons
Ratio of 3:1 glial cell:nerve cell > large number of glial cells in the brain
Do not have axons or dendrites
Types of glial cell
Astrocytes (biggest glial cell)
Oligodendrocytes
Microglial cell
Schwann cell
Ependymal cell
Presenting symptoms
Depends upon location of tumour (Slow growing undetected until cause symptoms due to growth)
Less likely focal neurological deficits e.g. weakness, aphasia
(Cells infiltrate (not destroy/compress cortex))
Headaches
(increased pressure due to obstruction – hydrocephalus (vision disturbances, nausea & vomiting) which raises ICP)
Seizures
(Partial/focal/tonic-clonic (grand mal))
Aphasia – language disorder, expression and comprehension
Hydrocephalus isa neurological disorder caused by an abnormal build-up of cerebrospinal fluid in the ventricles deep within the brain. This excess fluid causes the ventricles to widen, putting harmful pressure on the brain’s tissues
Investigations
Clinical:
Full medical history
Aetiological factors - very little links aetiologically (main one > radiation)
Histopathology:
Via biopsy
May only be completed when having surgery
Stereotactic needle biopsy
Atypia - differentiation of cells > how typical they look under microscope
Anaplasia (cell differentiation)
Microscope proliferation
Necrosis
Imaging:
CT
Low tumour density
Oligodendrogliomas – calcification & patchy contrast enhanced (not ring enhanced HGG)
MRI
T2 weighted, FLAIR, DWI series & T1 pre- and post- contrast
MRI perfusion & MR spectroscopy – if concerns about possible high grade transformation
Oligodendrogliomas
IDH mutation AND 1p/19q co-deletion
Favourable prognosis
Astrocytoma
IDH mutation NO 1p/19q co-deletion probable TP53 mutations & ATRX mutation
Favourable prognosis
NO IDH mutation NOR 1p/19q co-deletion
Least favourable prognosis
Risk Factors, Prognostic Factors
Age ≥40 higher risk
Performance Status
Presenting Symptoms
(Seizures better prognosis as earlier diagnosis
Neurological deficits – poorer prognosis)
Tumour size & location (surgical location - ease of removal)
Management (Symptomatic)
Timing remains controversial
~6mths from radiological diagnosis
Safe maximal resection (most you can remove safely)
(Awake craniotomy inc language and functional monitoring
Neuroradiological support
Intraoperative neurophysiological monitoring
Intraoperative image guidance)
Management (Asymptomatic)
Consider active monitoring
Biopsy